The nanomagnetic relaxometry method we have developed can be used to specifically detect cancer cells while ignoring benign tumors. Because we use antibodies specific to cancer cells, and we are able to detect our nanoparticles linked to these antibodies only if they are also bound to cancer cells, we can both measure the number of cancer cells and localize these cells within the body. Sophisticated software is being developed to acquire and analyze the results from our nanomagnetic early detection devices.
Andrew Gomez, Senior Scientific’s Nanoparticle Product Development Engineer will be presenting a poster at the 9th International Conference on Fine Particle Magnetism entitled:
Superparamagnetic relaxometry (SPMR) as a Technique for Measuring Biodistribution of Superparamagnetic PrecisionMRX® Nanoparticles In Vivo
Click here to request more information about this presentation